Institutional investors purchased a net $19.0 million shares of AZN during the quarter ended June 2014 and now own 8.22% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LINGOHR & PARTNER NORTH AMERICA,... Bought 34.7 Thousand shares of AstraZeneca PLC
RUSSELL INVESTMENTS LTD. Bought 29.9 Thousand shares of AstraZeneca PLC